Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 9/2019

01-09-2019 | Hemangioma | Review

Uncommon imaging evolutions of focal liver lesions in cirrhosis

Authors: Federica Vernuccio, Roberto Cannella, Giorgia Porrello, Alberto Calandra, Massimo Midiri, Alessandro Furlan, Giuseppe Brancatelli

Published in: Abdominal Radiology | Issue 9/2019

Login to get access

Abstract

Objective

The purpose of this article is to describe and illustrate uncommon imaging evolutions of benign (i.e., cyst, hemangioma, focal nodular hyperplasia-like nodules, and hepatic angiomyolipoma) and malignant (i.e., HCC and non HCC malignancies) lesions in a cirrhotic liver. The content highlights relevant pathogenesis and imaging clues for proper differential diagnosis. Revision of prior imaging and knowledge of these scenarios may help the abdominal radiologist to reach a noninvasive diagnosis and direct the patient to the most appropriate clinical management.

Conclusion

Uncommon imaging evolutions of focal liver lesions in cirrhosis may represent a challenge for the abdominal radiologist, with atypical changes in size, and internal vascularization changes that may lead to misdiagnoses.
Literature
1.
2.
Cerny M, Bergeron C, Billiard JS, et al. LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features. Radiology. 2018; 288:118–128.CrossRefPubMed
3.
Brancatelli G, Federle MP, Blachar A, Grazioli L. Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology. 2001; 219:69–74.CrossRefPubMed
4.
Vernuccio F, Ronot M, Dioguardi Burgio M, et al. Uncommon evolutions and complications of common benign liver lesions. Abdom Radiol (NY) 2018; 43:2075–2096.CrossRef
5.
Huz JI, Melis M, Sarpel U. Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response. HPB (Oxford) 2012; 14:500–505.CrossRef
6.
7.
Motosugi U, Ichikawa T, Sou H, et al. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Radiology 2010; 256:151–158.CrossRefPubMed
8.
Galia M, Taibbi A, Marin D, et al. Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 2014; 20:222–228.CrossRefPubMedPubMedCentral
9.
Ding H, Wei H, Liu H, Chen Y, Xue X, Weng H. The Histopathological Features and CT/MRI Imaging Performances in Hepatic Angiomyolipoma Patients. Ann Hepatol 2017; 16:759–764.CrossRefPubMed
10.
Lee YH, Kim SH, Cho MY, Shim KY, Kim MS. Focal nodular hyperplasia-like nodules in alcoholic liver cirrhosis: radiologic-pathologic correlation. Am J Roentgenol 2007; 188:W459–W463.CrossRef
11.
Kitao A, Matsui O, Yoneda N, et al. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI. Am J Roentgenol 2018; 211:347–357.CrossRef
12.
Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 2000; 20:379–397.CrossRefPubMed
13.
Bartolozzi C, Cioni D, Donati F, Lencioni R. Focal liver lesions: MR imaging-pathologic correlation. Eur Radiol 2001; 11:1374–1388.CrossRefPubMed
14.
Dodd GD, Baron R, Oliver JH, Federle MP. Spectrum of imaging findings of the liver in end-stage cirrhosis: part II, focal abnormalities. Am J Roentgenol 1999; 173:1185–1193.CrossRef
15.
Duran R, Ronot M, Di Renzo S, Gregoli B, Van Beers BE, Vilgrain V. Is magnetic resonance imaging of hepatic hemangioma any different in liver fibrosis and cirrhosis compared to normal liver? Eur J Radiol 2015; 84:816–822.CrossRefPubMed
16.
Doyle DJ, Khalili K, Guindi M, Atri M. Imaging features of sclerosed hemangioma. Am J Roentgenol 2007; 189:67–72.CrossRef
17.
Ridge CA, Shia J, Gerst SR, Do RK. Sclerosed hemangioma of the liver: concordance of MRI features with histologic characteristics. J Magn Reson Imaging 2014; 39:812–818.CrossRefPubMed
18.
Chernyak V, Kobi M, Flusberg M, Fruitman KC, Sirlin CB. Effect of threshold growth as a major feature on LI-RADS categorization. Abdom Radiol (NY) 2017; 42:2089–2100.CrossRef
19.
Marrero JA, Kulik LM, Sirlin C, et al. Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2018; 68:723–750.CrossRefPubMed
20.
Tang A, Bashir MR, Corwin MT, et al. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. Radiology 2018; 286:29–48.CrossRefPubMed
21.
Fraum TJ, Tsai R, Rohe E, et al. Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014. Radiology 2018; 286:158–172.CrossRefPubMed
22.
23.
Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND. Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. Am J Surg Pathol 1998; 22:656–662.CrossRefPubMed
24.
Matsui O. Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology 2004; 47:271–276.CrossRefPubMed
25.
Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 2005; 11:281–289.CrossRefPubMed
26.
Fowler KJ, Sheybani A, Parker RA 3rd, et al. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. Am J Roentgenol 2013; 201:332–339.CrossRef
27.
Huang B, Wu L, Lu XY, et al. Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging. Radiology 2016; 281:150–157.CrossRefPubMed
28.
Potretzke TA, Tan BR, Doyle MB, Brunt EM, Heiken JP, Fowler KJ. Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases. AJR Am J Roentgenol 2016; 207:25–31.CrossRefPubMed
29.
Tanabe M, Kanki A, Wolfson T, et al. Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2, 3, and 4 Observations Detected at CT and MR Imaging. Radiology 2016; 281:129–139.CrossRefPubMed
30.
Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg 2015; 261:947–955.CrossRefPubMed
31.
Roayaie S, Obeidat K, Sposito C, et al. Resection of hepatocellular cancer ≤2 cm: results from two Western centers. Hepatology 2013; 57:1426–1435.CrossRefPubMed
32.
Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234:961–967.CrossRefPubMed
33.
Khan KN, Yatsuhashi H, Yamasaki K, et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000; 32:269–278.CrossRefPubMed
34.
Tezuka M, Hayashi K, Kubota K, et al. Growth rate of locally recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization: comparing the growth rate of locally recurrent tumor with that of primary hepatocellular carcinoma. Dig Dis Sci 2007; 52:783–788.CrossRefPubMed
Metadata
Title
Uncommon imaging evolutions of focal liver lesions in cirrhosis
Authors
Federica Vernuccio
Roberto Cannella
Giorgia Porrello
Alberto Calandra
Massimo Midiri
Alessandro Furlan
Giuseppe Brancatelli
Publication date
01-09-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 9/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02101-4

Other articles of this Issue 9/2019

Abdominal Radiology 9/2019 Go to the issue

Pelvis

Texture analysis of placental MRI: can it aid in the prenatal diagnosis of placenta accreta spectrum?

Hollow Organ GI

Acute non-traumatic abdominal pain by quadrant: relative yield of CT and clinical evaluation for diagnosis in 1000 patients

Society Report

Society of abdominal radiology gastrointestinal bleeding disease-focused panel consensus recommendations for CTA technical parameters in the evaluation of acute overt gastrointestinal bleeding

Hollow Organ GI

Performance of a machine learning-based decision model to help clinicians decide the extent of lymphadenectomy (D1 vs. D2) in gastric cancer before surgical resection

Hepatobiliary

Liver stiffness obtained by ElastPQ ultrasound shear wave elastography independently determines mean right atrial pressure

Classics in Abdominal Radiology

Classics in abdominal radiology: a “scrotal pearl”

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits